Epigenetic Modulation of DDIT3 and MGMT Expression Acts Synergistically with Resistance to Imatinib towards CML Disease Progression: A Hospital based Study.
Gautam HazarikaManash Jyoti KalitaSimanta KalitaPartha Pratim DasKalpajit DuttaLipika LahkarAnjanjyoti RajkonwarMohammed Ghaznavi IdrisVinotsale KhamoGiriraj KusreSubhash MedhiPublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
In the present study notable depletion of survivality was established in the Imatinib resistance patients manifesting genetic malfunction of BCR-ABL transcripts among the North East Indian inhabitants and advocating for the expansion of the disease.
Keyphrases
- chronic myeloid leukemia
- end stage renal disease
- ejection fraction
- newly diagnosed
- tyrosine kinase
- chronic kidney disease
- gene expression
- poor prognosis
- healthcare
- acute lymphoblastic leukemia
- dna methylation
- prognostic factors
- emergency department
- genome wide
- patient reported outcomes
- tertiary care
- patient reported